|  Help  |  About  |  Contact Us

Publication : Epidermal overexpression of transgenic ΔNp63 promotes type 2 immune and myeloid inflammatory responses and hyperplasia via NF-κB activation.

First Author  Du J Year  2014
Journal  J Pathol Volume  232
Issue  3 Pages  356-68
PubMed ID  24258200 Mgi Jnum  J:207938
Mgi Id  MGI:5559962 Doi  10.1002/path.4302
Citation  Du J, et al. (2014) Epidermal overexpression of transgenic DeltaNp63 promotes type 2 immune and myeloid inflammatory responses and hyperplasia via NF-kappaB activation. J Pathol 232(3):356-68
abstractText  DeltaNp63 is known to be critical in skin development and cancer; however, how it triggers proliferation and inflammation in vivo remains to be elucidated. Here, we find that induced DeltaNp63 expression in skin of transgenic mice (TG) results in a hyperproliferative epidermis coupled with inflammatory infiltrates. In situ, infiltrating cells include CD45(+) leukocytes, CD19(+) B lymphocytes, CD3(+) T lymphocytes, CD4(+) T helper, CD25(+)/Foxp3(+) Treg, Ly6B(+) neutrophils, S-100(+) dendritic cells, and macrophages bearing CD11b(+), F4/80(+), CD68(+), and CD206(+) M2 type markers. Transcriptional profiling of TG skin revealed increased gene expression involved in inflammation and immune responses, including Th2/M2 cytokines and chemokines. These genes were co-regulated by DeltaNp63 and NF-kappaB RelA or cRel, and enhanced by TNF-alpha. Elevated cRel, RelA, and IKKs were observed in TG mouse skin and human squamous carcinomas with DeltaNp63 overexpression. Thus, our findings unveil a missing link connecting overexpressed DeltaNp63 with aberrant NF-kappaB activation, pro-inflammatory and type 2 cytokines and chemokines, and host infiltrates during skin inflammation and hyperplasia. Our findings provide a missing link between DeltaNp63 overexpression and NF-kappaB-mediated inflammation, of potential relevance to the pathogenesis of squamous carcinoma.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

5 Bio Entities

Trail: Publication

0 Expression